HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Greg A Gerhardt Selected Research

Diffuse Brain Injuries (Diffuse Brain Injury)

4/2012Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury.
3/2012Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.
1/2012Hypersensitive glutamate signaling correlates with the development of late-onset behavioral morbidity in diffuse brain-injured circuitry.
5/2010Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Greg A Gerhardt Research Topics

Disease

28Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2002
10Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2019 - 03/2005
6Neurodegenerative Diseases (Neurodegenerative Disease)
07/2012 - 10/2002
4Substance-Related Disorders (Drug Abuse)
12/2021 - 08/2015
4Diffuse Brain Injuries (Diffuse Brain Injury)
04/2012 - 05/2010
3Ischemia
06/2020 - 01/2010
3Seizures (Absence Seizure)
11/2017 - 11/2014
3Brain Injuries (Brain Injury)
01/2017 - 05/2010
3Mental Disorders (Mental Disorder)
08/2015 - 12/2010
3Dyskinesias (Dyskinesia)
01/2013 - 02/2009
2Central Nervous System Diseases (CNS Diseases)
01/2020 - 01/2017
2Neuroinflammatory Diseases
12/2019 - 03/2012
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2017
2Dementia (Dementias)
01/2017 - 03/2012
2Movement Disorders (Movement Disorder)
01/2016 - 01/2007
2Atrophy
03/2012 - 02/2007
2Ataxia (Dyssynergia)
03/2012 - 10/2006
2Epilepsy (Aura)
07/2011 - 07/2011
2Pain (Aches)
07/2011 - 06/2004
2Parkinsonian Disorders (Parkinsonism)
02/2008 - 08/2005
1Brain Neoplasms (Brain Tumor)
01/2022
1Wounds and Injuries (Trauma)
06/2020
1Status Epilepticus (Complex Partial Status Epilepticus)
11/2017
1Neoplasms (Cancer)
10/2017
1Cognitive Dysfunction
10/2017
1Necrosis
04/2017
1Infections
04/2017
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2015
1MPTP Poisoning
02/2015
1Inflammation (Inflammations)
03/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
04/2012
1Hypersensitivity (Allergy)
01/2012
1Postherpetic Neuralgia
07/2011
1Anxiety Disorders (Anxiety Disorder)
07/2011
1Diabetic Neuropathies (Diabetic Neuropathy)
07/2011
1Fibromyalgia (Fibrositis)
07/2011
1Major Depressive Disorder (Major Depressive Disorders)
07/2011
1Schizophrenia (Dementia Praecox)
12/2010
1Hypoxia (Hypoxemia)
11/2007
1Stroke (Strokes)
11/2007
1Hypokinesia (Bradykinesia)
11/2006

Drug/Important Bio-Agent (IBA)

20Glutamic Acid (Glutamate)FDA Link
01/2019 - 11/2007
13Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
10/2020 - 01/2002
13Dopamine (Intropin)FDA LinkGeneric
01/2016 - 10/2002
6Nerve Growth Factors (Neurotrophins)IBA
12/2018 - 01/2002
4Neurotransmitter Agents (Neurotransmitter)IBA
01/2017 - 12/2007
4Levodopa (L Dopa)FDA LinkGeneric
01/2013 - 10/2002
3Pharmaceutical PreparationsIBA
01/2018 - 10/2015
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2015 - 11/2006
3PotassiumIBA
01/2013 - 05/2010
3Amphetamine (Amfetamine)FDA LinkGeneric
04/2007 - 03/2005
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2003
2Methylphenidate (Ritalin)FDA LinkGeneric
01/2019 - 03/2005
2Cocaine (Cocaine HCl)IBA
01/2019 - 01/2016
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
04/2017 - 03/2012
2AdderallIBA
04/2007 - 03/2005
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
04/2007 - 03/2005
2SaltsIBA
04/2007 - 03/2005
2IronIBA
02/2007 - 10/2005
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
12/2021
1Oxygen (Dioxygen)IBA
06/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1DSP 4 (DSP-4)IBA
12/2019
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2019
1Pilocarpine (Ocusert)FDA LinkGeneric
11/2017
1PlatinumIBA
11/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017
1RiluzoleFDA LinkGeneric
10/2015
14-Aminopyridine (4 Aminopyridine)FDA Link
11/2014
1CatecholaminesIBA
08/2014
1Carbon Fiber (Grafil)IBA
12/2012
1CalciumIBA
04/2012
1salicylhydroxamic acid (SHAM)IBA
03/2012
1Prostaglandins BIBA
07/2011
1Gabapentin (Neurontin)FDA LinkGeneric
07/2011
1Biogenic Amines (Biogenic Amine)IBA
07/2011
1Pregabalin (Lyrica)FDA Link
07/2011
1EnzymesIBA
05/2010
1Potassium ChlorideFDA LinkGeneric
05/2010
1antineoplaston A10 (A 10)IBA
02/2010
1Trichloroethylene (Trichloroethene)IBA
02/2008
1MetalsIBA
02/2008
1NeurotoxinsIBA
02/2008
1ApomorphineFDA Link
11/2006
1Dopamine Agents (Dopaminergic Agents)IBA
11/2006
1Ethanol (Ethyl Alcohol)IBA
10/2006
1Dexmethylphenidate HydrochlorideFDA LinkGeneric
03/2005
1Bone Morphogenetic Protein 7IBA
06/2004
1Peptides (Polypeptides)IBA
01/2003

Therapy/Procedure

10Therapeutics
01/2020 - 01/2003
7Microelectrodes
11/2017 - 05/2010
3Deep Brain Stimulation
04/2021 - 01/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2021
1Critical Care (Surgical Intensive Care)
06/2020
1Self Administration (Administration, Self)
01/2019
1Catheters
04/2017
1Electrodes (Electrode)
01/2017
1Prostheses and Implants (Prosthesis)
01/2017
1Operative Surgical Procedures
01/2010
1Caloric Restriction
12/2004